Cardiac biomarkers in systemic sclerosis: Contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide

Arthritis Care and Research

Volumn 67, Issue 7, 2015, Pages 1022-1030

  Avouac, Jérôme ^a   Meune, Christophe ^b,f   Chenevier Gobeaux, Camille ^c   Borderie, Didier ^c   Lefevre, Guillaume ^d   Kahan, André ^e   Allanore, Yannick ^a  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c HÔTEL DIEU   (France)

^d HÔPITAL TENON   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f University of Paris   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; TROPONIN T; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHEMOLUMINESCENCE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC SCLEROSIS; BLOOD; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDY; MIDDLE AGED; SCLERODERMA, SYSTEMIC; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RISK FACTORS; SCLERODERMA, SYSTEMIC; TROPONIN T; YOUNG ADULT;

EID: 84932613567     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22547     Document Type: Article

References (32)

1. Kahan A, Allanore Y., Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford) 2006; 45 Suppl 4: iv14-7.
2. Elhai M, Meune C, Avouac J, Kahan A, Allanore Y., Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2012; 51: 1017-26.
3. Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al., Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010; 69: 1809-15.
4. Chenevier-Gobeaux C, Meune C, Blanc MC, Cynober L, Jaffray P, Lefevre G., Analytical evaluation of a high-sensitivity troponin T assay and its clinical assessment in acute coronary syndrome. Ann Clin Biochem 2011; 48: 452-8.
5. Januzzi JL Jr, Bamberg F, Lee H, Truong QA, Nichols JH, Karakas M, et al., High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation 2010; 121: 1227-34.
6. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, et al., A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009; 361: 2538-47.
7. Meune C, Reichlin T, Irfan A, Schaub N, Twerenbold R, Meissner J, et al., How safe is the outpatient management of patients with acute chest pain and mildly increased cardiac troponin concentrations? Clin Chem 2012; 58: 916-24.
8. Filusch A, Giannitsis E, Katus HA, Meyer FJ., High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertension. Clin Sci (Lond) 2010; 119: 207-13.
9. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al., Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655-63.
10. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004; 110: 2168-74.
11. Halim SA, Newby LK, Ohman EM., Biomarkers in cardiovascular clinical trials: past, present, future. Clin Chem 2012; 58: 45-53.
12. Allanore Y, Meune C., N-terminal pro brain natriuretic peptide: the new cornerstone of cardiovascular assessment in systemic sclerosis. Clin Exp Rheumatol 2009; 27: 59-63.
13. Chighizola C, Meroni PL, Schreiber BE, Coghlan JG, Denton CP, Ong VH., Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients. Clin Exp Rheumatol 2012; 30: S81-5.
14. Thakkar V, Stevens WM, Prior D, Moore OA, Byron J, Liew D, et al., N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Res Ther 2012; 14: R143.
15. Allanore Y, Meune C, Vonk MC, Airo P, Hachulla E, Caramaschi P, et al., Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of systemic sclerosis patients. Ann Rheum Dis 2010; 69: 218-21.
16. Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, et al., Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J 2006; 27: 1485-94.
17. Allanore Y, Wahbi K, Borderie D, Weber S, Kahan A, Meune C. N-, terminal brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment? Ann Rheum Dis 2009; 68: 1885-9.
18. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al., 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013; 72: 1747-55.
19. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Jr., et al., Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
20. Avouac J, Meune C, Chenevier-Gobeaux C, Dieude P, Borderie D, Lefevre G, et al., Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors. J Rheumatol 2014; 41: 248-55.
21. Avouac J, Airo P, Meune C, Beretta L, Dieude P, Caramaschi P, et al., Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol 2010; 37: 2290-8.
22. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA., Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010; 56: 254-61.
23. Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, et al., High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum 2008; 58: 284-91.
24. Montagnana M, Lippi G, Volpe A, Salvagno GL, Biasi D, Caramaschi P, et al., Evaluation of cardiac laboratory markers in patients with systemic sclerosis. Clin Biochem 2006; 39: 913-7.
25. Constans J, Skopinski S, Barcat D, Conri C., [Cardiovascular involvement in systemic sclerosis]. Ann Med Interne (Paris) 2002; 153: 242-9.
26. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al., Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002; 81: 139-53.
27. Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, et al., Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum 2007; 56: 2740-6.
28. Torbicki A, Kurzyna M, Kuca P, Fijalkowska A, Sikora J, Florczyk M, et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003; 108: 844-8.
29. Roy AK, McCullagh BN, Segurado R, McGorrian C, Keane E, Keaney J, et al., Detection of high-sensitivity troponin in outpatients with stable pulmonary hypertension identifies a subgroup at higher risk of adverse outcomes. J Card Fail 2014; 20: 31-7.
30. Heresi GA, Tang WH, Aytekin M, Hammel J, Hazen SL, Dweik RA., Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension. Eur Respir J 2012; 39: 939-44.
31. Meune C, Avouac J, Airo P, Beretta L, Dieude P, Wahbi K, et al., Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations. Arthritis Rheum 2011; 63: 2790-6.
32. Meune C, Avouac J, Wahbi K, Cabanes L, Wipff J, Mouthon L, et al., Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis Rheum 2008; 58: 1803-9.